ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0039003;pronephric field specification;6.0;1.0;0.8231203125901445;9.628524252492122;42.10399314002567;9.083926447120524;0.001409182759262934;0.7876727335416686;[PAX2]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[NRP1, NLGN1, CCL21, FMR1, ARAP1, CCR7]
GO:0002087;regulation of respiratory gaseous exchange by neurological system process;6.0;1.0;0.8231203125901445;9.628524252492122;40.361908422019745;7.212124270218933;0.0013508767515257331;0.6919486831672181;[NLGN1]
GO:0022010;central nervous system myelination;5.0;1.0;0.7902410118609202;9.628524252492122;21.182224696661116;7.379178354882098;7.0894999783268E-4;0.6676125360964777;[PLP1, ASPA]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, GMNN, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CIITA, FHL2, FASLG, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, RBBP8, E2F1, E2F7, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, PURA, RXRA, CDX2, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[NLGN4Y, NLGN1, SYT2, KIAA1109, SNCA]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, ADARB1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, LINGO1, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:0072189;ureter development;4.0;1.0;0.75;9.628524252492122;30.207912033305377;8.390779266560578;0.0010110316303989237;0.6791048419030481;[PAX2]
GO:0072221;metanephric distal convoluted tubule development;9.0;1.0;0.896240625180289;9.628524252492122;197.78996342219313;8.390779266560578;0.0066198520763304245;0.8253454670833372;[PAX2]
GO:2000594;positive regulation of metanephric DCT cell differentiation;8.0;1.0;0.875;9.628524252492122;268.93043587634327;9.083926447120524;0.009000859667102299;0.839552420951524;[PAX2]
GO:0050679;positive regulation of epithelial cell proliferation;6.0;0.7192862368539868;0.682763431017138;8.647694999480395;65.06748660449396;4.584116776790259;0.002177750219716307;0.5575522577384293;[NRP1, NRP2, ECM1, ITGB3, HMGB2, IHH, TNFAIP3, LAMC1, CDH3, AKT1, IL10, PPP1R16B, GHSR, MED1, ITGA4, ARG1, SIRT1, F3, PAX2, NME1, MMP12, AGTR1, C5AR1, HTRA1, TGFA, TWIST1, NOD2, IQGAP3, CCL5, HMOX1, PLCG1, JUN, TGFB1, EGR3, CAV2, TNFSF12, LAMB1, NR4A1, BMP2, LRG1, CXCL12, NR4A3, ID1, TEK]
GO:0035435;phosphate ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;110.11210983553856;7.138016298065211;0.003685353221730381;0.7400384854347593;[ANKH, SLC17A1]
GO:0072108;positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;8.0;1.0;0.875;9.628524252492122;682.945505833763;8.390779266560578;0.022857571469204727;0.8041048419030481;[LIF, PAX2]
GO:2000597;positive regulation of optic nerve formation;7.0;1.0;0.8509193652572005;9.628524252492122;134.46464362666197;9.777073627680469;0.004500410611861768;0.8509193652572005;[PAX2]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[KCNK5, KCNG2, KCNE3, KCNE4, SLC1A3, KCNA5, AQP1, KCNMB3, KCNN3, KCNH1, SLC12A2, KCNH2, KCND2, SLC12A1, KCNIP4, KCNJ15, KCNJ16, ATP1B2, ATP1B1, KCNQ1, FXYD2]
GO:1904861;excitatory synapse assembly;5.0;1.0;0.7902410118609202;9.628524252492122;37.238733880868345;8.16763571524637;0.0012463469103079984;0.7079342821725234;[NLGN1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, RXRA, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0060999;positive regulation of dendritic spine development;11.0;0.9326813400603323;0.8987696223598284;9.596775554177542;671.848150157114;6.113511981550823;0.022486152961678982;0.7450742393735527;[NLGN1, FMR1, CAMK1, SHANK3]
GO:1900029;positive regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;7.138016298065211;0.006704083591926775;0.7612791106150483;[EPS8, CYFIP1, NLGN1, EPS8L1, EPS8L3, PFN1]
GO:2000809;positive regulation of synaptic vesicle clustering;7.0;1.0;0.8509193652572005;9.628524252492122;59.688833127145365;8.16763571524637;0.001997731528303309;0.7686126355688037;[NLGN1]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[HOMER3, SEC63, ZFYVE16, AKAP12, SRP9, HSD17B4, NEDD4, SCARB2, NCF1, ZFAND6, CLU, LAMP2, HGS, SLC27A2, EHHADH, NUP54, NLGN1, VPS41]
GO:0090190;positive regulation of branching involved in ureteric bud morphogenesis;8.0;1.0;0.875;9.628524252492122;298.04283299406984;6.832634648514029;0.009975225399176214;0.7244212536750128;[GREM1, TGFB1, HOXB7, LGR4, PAX2]
GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;100.75338661320167;7.697632086000634;0.0033721251777828433;0.7167775754447168;[GREM1, PAX2]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[MCM7, AKT1, PLCG1, MED1, CAD, PAX2, COL1A1, VIL1, ID1, SNAI2]
GO:0071526;semaphorin-plexin signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.089527751759436;26.50247477320489;6.166155715036245;8.87013979980389E-4;0.6384578026126634;[NRP1, SEMA5B, NRP2, SEMA6A, PLXND1, SEMA4B, ARHGDIA, FLNA, PLXNB2]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[CUBN, CH25H, CFTR, CEBPA, RXRA, ABCA1, DHCR24, SNX17]
GO:1901642;nucleoside transmembrane transport;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;64.93336740067564;7.8311634786251565;0.0021732613706639545;0.7514054297404357;[SLC28A1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RXRA, IL33, CDX1, OSM, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MSR1, CUBN, LRP1, CD36, LRP2, ZDHHC17]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[CD40, TGFB1, TSC2, TNF, PAX2, TMEM100, CCL5, IL1B, AKT1, CCL2, EPHA2]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[CPNE8, NLGN1, CAMK2D, CPNE5, SERPINE1, PHB2, ECT2, JUNB, KCNH1, MEF2A, MEF2C, JUN, EDN1, FOS, TUBG1, FOSB]
GO:0097104;postsynaptic membrane assembly;5.0;1.0;0.7902410118609202;9.628524252492122;57.45028169597201;7.57984905034425;0.001922809226467428;0.6778748447945537;[NLGN4Y, NLGN1]
GO:0023041;neuronal signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;7.9853141584524145;7.75488093814194E-4;0.6986103492792611;[NLGN1]
GO:0097105;presynaptic membrane assembly;5.0;1.0;0.7902410118609202;9.628524252492122;57.45028169597201;7.474488534686424;0.001922809226467428;0.6724867031240476;[NLGN4Y, NLGN1]
GO:0015889;cobalamin transport;5.0;1.0;0.7902410118609202;9.628524252492122;71.58361141623146;7.697632086000634;0.0023958390530335622;0.6838982747154925;[CUBN, TCN1, CD320]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:0050908;detection of light stimulus involved in visual perception;7.0;1.0;0.8509193652572005;9.628524252492122;116.24341103924905;6.943860283624253;0.003890562355205735;0.7060287030842711;[SEMA5B, CACNA1F, BEST1]
GO:0002072;optic cup morphogenesis involved in camera-type eye development;6.0;1.0;0.8231203125901445;9.628524252492122;34.30953406247527;9.083926447120524;0.0011483092284950683;0.7876727335416686;[PAX2]
GO:0048789;cytoskeletal matrix organization at active zone;6.0;1.0;0.8231203125901445;9.628524252492122;21.934314412845083;9.777073627680469;7.341217637965568E-4;0.8231203125901445;[NLGN1]
GO:1901379;regulation of potassium ion transmembrane transport;8.0;0.6369964171292115;0.6934982085646058;8.679443697794976;69.40502590152681;5.514393750639154;0.002322923756456068;0.6570063528532206;[KCNE3, FLNA, KCNH2, CAV1, KCNIP4, ATP1B2, ATP1B1, DNM2, KCNQ1, NEDD4]
GO:0097113;AMPA glutamate receptor clustering;9.0;1.0;0.896240625180289;9.628524252492122;45.884964450884205;8.390779266560578;0.0015357284663841083;0.8253454670833372;[NLGN1, SHANK3]
GO:0097115;neurexin clustering involved in presynaptic membrane assembly;7.0;1.0;0.8509193652572005;9.628524252492122;44.498670089768545;9.777073627680469;0.001489330441701492;0.8509193652572005;[NLGN1]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[CYFIP1, NRP1, SEMA5B, NRP2, ALCAM, MAP1B, VCL]
GO:0097114;NMDA glutamate receptor clustering;8.0;1.0;0.875;9.628524252492122;45.884964450884205;8.390779266560578;0.0015357284663841083;0.8041048419030481;[NLGN1, SHANK3]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, HDAC2, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, GREM1, BMP2, BCL2]
GO:0097119;postsynaptic density protein 95 clustering;6.0;1.0;0.8231203125901445;9.628524252492122;32.82490209968103;7.9853141584524145;0.0010986199327823658;0.7314896500084853;[NLGN1, LRRC4]
GO:0015812;gamma-aminobutyric acid transport;9.0;0.8436909121759173;0.8180860812682478;9.434368238051164;135.2317479943229;7.697632086000634;0.004526084904698269;0.7898978880348613;[SLC6A13, SLC6A12]
GO:0010001;glial cell differentiation;4.0;0.7192862368539868;0.6096431184269935;8.404748820870006;21.066225782797595;5.528578385631111;7.050676185779127E-4;0.5327317557463623;[LEF1, FGF5, DUSP10, TSPAN2, CSK, GPR157, EGR2, CDKN2C, PAX2, PLP1]
GO:2000302;positive regulation of synaptic vesicle exocytosis;11.0;0.8259837884571596;0.845420846558242;9.533214072687796;1061.769420372717;8.67846133901236;0.03553646696943479;0.8762458687964789;[NLGN1]
GO:1902474;positive regulation of protein localization to synapse;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;25.478761436601122;7.8311634786251565;8.527512158864491E-4;0.7236063770733796;[NLGN1]
GO:1902358;sulfate transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;123.29733532969695;7.069023426578259;0.0041266508530873195;0.7365101867784198;[SLC13A1, SLC26A8, SLC26A7, SLC26A11, SLC26A3]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[EHF, SPI1, CCNH, SPIB, MYB, HOXA7, JUNB, HOXA5, SOX4, MEF2A, MED1, MEF2C, HOXB3, HOXB2, HOXB7, ATF3, HOXB5, TXK, GATA3, GATA1, NHLH2, RAD21, EGR1, EGR2, JUN, BCL11B, TGFB1I1, BRCA1, HOXC10, PAX5, FOS, SIRT1, PAX2, PLSCR1, TFEC, SATB2, FLNA, CDX2, CDX1, GTF2H1, GRHL2, POU4F1, FOSB, CCNT2, ARID4A, ETS1, HOXA10, LMO2, C5AR1, HMGA1, NFKB1, NFKB2, COPS5, MAFB, FEV, MAFF, ARRB1, ARRB2, MYBL1, MYOCD, KLF13, NCBP2, ETV1, TFDP1, ELF3, IRF7, CREB5, CEBPA, CEBPB, CEBPD, CEBPE, TAF9, LEF1, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, PRRX1, KLF4, MEIS2, MEIS1, KLF6, KLF5, POU2AF1, TAF5, RBMX]
GO:0009235;cobalamin metabolic process;5.0;0.8436909121759173;0.712086467948879;9.456673995565463;140.1686978913012;6.7325511899570465;0.004691320174783688;0.6345439928109722;[CUBN, TCN1, PRSS3, CD320]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[CD74, NLGN1, RRM1, NUP54]
GO:1900215;negative regulation of apoptotic process involved in metanephric collecting duct development;9.0;1.0;0.896240625180289;9.628524252492122;334.77730014508865;9.083926447120524;0.011204694955846741;0.8607930461318132;[PAX2]
GO:1900218;negative regulation of apoptotic process involved in metanephric nephron tubule development;9.0;1.0;0.896240625180289;9.628524252492122;334.77730014508865;9.083926447120524;0.011204694955846741;0.8607930461318132;[PAX2]
GO:0046415;urate metabolic process;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;153.84051102177276;7.212124270218933;0.005148903456427586;0.659069382437994;[SLC17A1, SLC17A3, ABCG2, SLC22A11]
GO:0048714;positive regulation of oligodendrocyte differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;471.693664190925;6.943860283624253;0.01578716244373315;0.7703503496879909;[HDAC2, CXCR4, ASPA, TLR2]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ICAM1, LGALS1, SOX4, MEN1, PAX2, NME1, LIN28A, IL1B, NOX4]
GO:0072300;positive regulation of metanephric glomerulus development;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;324.6246288901019;8.16763571524637;0.010864894185753253;0.7926932703116032;[EGR1, PAX2]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, ARRB1, ARRB2, AQP1, LAMP3, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, BIRC2, BIRC3, LEF1, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4, FABP1, VIL1, CD27]
GO:2000311;regulation of AMPA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.558197802812269;0.006718796083723233;0.7316271658034954;[MEF2C, NLGN1, ADRB2, SHANK3]
GO:0072305;negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;1390.2414855290351;9.083926447120524;0.04653013138455046;0.8969813732811862;[PAX2]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[MEF2C, NLGN1, DAPK1, EPHB2]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A2, SLC24A1, NLGN1, PLK2, ITPR3, PRKCZ, TNR, SHANK3, SNCA]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[ADCYAP1, NLGN1, TNR, PTGS2, KMO, SHANK3]
GO:0015747;urate transport;7.0;1.0;0.8509193652572005;9.628524252492122;46.61312809093599;7.292166977892469;0.0015600994481119112;0.7238411236270654;[SLC17A1, SLC17A3, SLC22A11]
GO:0015746;citrate transport;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;69.26890205252035;7.9853141584524145;0.002318367813733332;0.8046099625986299;[SLC13A1]
GO:0072307;regulation of metanephric nephron tubule epithelial cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;122.78518948428719;7.8311634786251565;0.004109509792542791;0.7754860644832351;[YAP1, LIF, PAX2]
GO:0061002;negative regulation of dendritic spine morphogenesis;12.0;1.0;0.9481203125901445;9.628524252492122;1979.5057838953023;7.9853141584524145;0.06625227714743111;0.8564896500084854;[NLGN1]
GO:0015760;glucose-6-phosphate transport;7.0;1.0;0.8509193652572005;9.628524252492122;35.11430155034197;7.9853141584524145;0.0011752440720702493;0.7592887026755414;[SLC17A3]
GO:1904823;purine nucleobase transmembrane transport;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;77.53080622993028;8.67846133901236;0.002594886311320219;0.7947362817240173;[AQP9, SLC28A1]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[NRP1, SEMA5B, SEMA6A, SEMA4B]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[SCARB2, SPARC, TFRC, HP, CXCL16, LOXL2, AP2M1, CUBN, HSPG2, RAB31, CALCRL, CFI, FPR2, ADRB2, IGLV1-44, CD14, IGHA1, MSR1, CD163, CAV2, CAV1, LRP1B, MARCO, DAB2, IGKV3-20, LRP12, ACHE, ITGB2, ADM, ARRB1, ARRB2, ASGR1, ASGR2, STAB1, CD36, FCER1G, SYK, ITGA4, DNM2, CEACAM1, COLEC12, LRP1, CD5L, TMPRSS2, LRP2, DLL1, IGKC, CXCR1, CXCR2, FCGR1A, FCGR1B, SNCA, LILRB1, CD6, SNX17, CD5, NEDD4, CD9, FCGR2B, RAMP1]
GO:0006139;nucleobase-containing compound metabolic process;4.0;0.2927628446114555;0.39638142230572776;5.401027157282536;96.27736604478845;1.3632429492593854;0.0032223167975150343;0.31971630782240534;[POP5, SPI1, SPIB, DPYSL2, MNX1, MTHFD1, ATF3, SLBP, CDCA5, CDCA7, GATA3, GATA1, JUN, EIF2AK2, NR2F2, ACHE, DPYS, HOXC10, CHAF1B, CHAF1A, ATIC, RMI1, FOS, MED23, PLSCR1, DPYD, ZNF467, CASP8AP2, ATAD2, CENPF, PKN1, MSH6, MSH2, BLM, UQCRB, GMPS, UQCRH, ZNF423, CIITA, HHEX, EXO1, ACPP, E2F1, E2F2, E2F5, E2F7, NOP56, POU2AF1, EIF3E, SMARCAL1, IKZF1, LGALS3, SNRPD2, SNRPD1, TRIM25, SNRPD3, CDC34, KCNQ1, BTK, GSPT1, EGR1, EGR2, EGR3, POLA1, BST1, POLA2, ALDH6A1, APOBEC3A, DEPDC1, YAP1, PCNA, COX5B, IL33, ETS1, NR3C2, LOXL2, KMO, CARD11, TCF7, LPXN, NASP, TCF4, MXD1, LYL1, MYBL1, MYOCD, CAD, ETV1, ELF3, ZMYND11, POLD3, POLD1, TBX21, RRM1, RRM2, POLE2, CDA, ADARB1, SMC3, PHB2, ADCY9, PRDM16, BARD1, NFE2, SNAI2, CDKN1A, BTG2, TK1, ZNF367, RARA, GART, NR1I2, ASCL2, USP1, NR1H2, NR1H4, ELP4, FOSB, TLE4, PGD, NRBP1, SNRPG, SNRPE, SNRPF, SNRPA, AEBP1, MAP2K6, FANCI, FANCG, COPS5, BCL6, BCL3, MCM7, LBH, RFC5, RFC3, ADSL, RFC4, RFC1, RFC2, BPGM, SMC1A, TFDP1, MCM3, MCM4, MCM6, MCM2, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, TTR, ABLIM3, POLR2E, POLR2I, POLR2J, POLR2K, POLR2L, SLC35A3, PML, DNAJA3, SLC35B3, GFI1, AQP1, PPP2R1A, MAGOH, ESCO2, SUCLG1, TXK, TWIST1, TOP2A, PARP9, CBFA2T3, GUCY2C, DTYMK, TYMP, PURA, NT5E, MPP1, GINS2, MLH1, GRHL2, CD40LG, HOXA11, HOXA10, LIG1, LMO2, ATP1B1, PUS7, ATP5J2, FANCD2, NLRP3, CBX4, KDM5D, HK3, TOPBP1, H2AFX, AXIN2, DCK, OAS3, LTF, LEF1, HLX, RBMX, EHMT2, MEF2A, MEF2C, RNASE6, RNASE3, RNASE2, UPB1, UQCRC1, PADI4, UQCRC2, FIGNL1, HESX1, MCTS1, HACE1, NOX1, EZH2, ACTL6A, SIRT1, PTGS2, UNG, STAT4, FLNA, PMS1, CCNT2, RORA, CTGF, RUVBL2, RUVBL1, ADCYAP1, MAZ, FOXO1, ACAT1, NFKB1, NFKB2, LRRK2, FHL2, FASLG, ARRB1, ARRB2, UPP1, DBF4, BIRC5, DTL, BIRC2, PRRX1, DONSON, CCNH, CCNC, UXT, ENTPD1, HNF1B, EREG, EPHA2, ATP5J, ATP5I, ATP5H, ATP5O, ATP5L, PCBP3, ERI2, ZNF700, PAICS, ID1, SUV39H1, HNF4G, BRCA1, BRCA2, BMI1, HNF4A, CD38, CCR6, SATB2, RXRA, RPA1, RPA3, FOXA3, FOXA2, DCLRE1A, GIMAP7, EOMES, CCNE2, CCNE1, PSMD14, CYC1, VDR, HMGA1, ISG15, DDX3Y, HMGB2, AFF3, NUP62, SULT4A1, NCBP2, IRF7, IRF8, CREB5, RBM47, TAF9, SAMHD1, RBM38, MAPK14, MAPK13, ACIN1, TAF5, NAA15, RAN, EHF, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB6, HOXB5, RAD21, NKX2-3, UPF3B, CDC6, TGFB1I1, ADM, PFAS, BRD2, PAWR, PAX5, PAX2, AES, GTF2H1, POU4F1, SLC28A1, FMR1, MACROD2, MEN1, NACC2, LSM5, LSM3, HOPX, MAFB, CNOT3, MAFF, CDK1, ESRP1, SMPDL3A, SMARCD3, RBBP8, ZNF503, IRX3, KLF4, KLF1, KLF8, RAD50, KLF6, RAD51, KLF5, IMPDH2, MNDA, ZNF608, CHEK1, DPF3, SOX7, SOX4, PTGDR, MCCC2, EBF1, RUNX2, AURKAIP1, NHLH2, BCL11B, BCL11A, TRMT11, FEN1, NME1, RAD51C, MDFIC, TFEC, FAM20C, SP100, PRIM1, RAD54B, RAD54L, CDX2, CDX1, ARID4A, ARID4B, FBL, CHCHD3, COL4A2, C5AR1, TGFB1, NR4A2, NR4A1, LIN28A, NR4A3, FEV, JMY, CREBZF, KYNU, PDE4B, KLF12, KLF13, PDE5A, PRTFDC1, HSPD1, GMDS, MEIS2, MEIS1, SSBP1]
GO:0006533;aspartate catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;824.4085624925121;8.67846133901236;0.027592212667087633;0.8590579283277371;[ASPA]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[NRP1, SEMA5B, SEMA6A, SEMA4B, LEF1, TWIST1, EDNRB]
GO:0098942;retrograde trans-synaptic signaling by trans-synaptic protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;46.63437644952677;9.777073627680469;0.0015608106115516636;0.8509193652572005;[NLGN1]
GO:0072531;pyrimidine-containing compound transmembrane transport;5.0;0.7866048967936545;0.6835434602577475;9.176539128749065;43.69743852505243;7.474488534686424;0.0014625139422920369;0.6724867031240476;[AQP9, SLC28A1, SLC19A2]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, KCNIP4, TSPAN15, EHD3, RAMP1]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, SOD2, TEK]
GO:0032230;positive regulation of synaptic transmission, GABAergic;8.0;1.0;0.875;9.628524252492122;135.4246808583232;7.212124270218933;0.0045325421940280546;0.7438283705770736;[NLGN1, CA2, PRKCE]
GO:1905520;positive regulation of presynaptic active zone assembly;9.0;1.0;0.896240625180289;9.628524252492122;390.905034801094;9.777073627680469;0.013083239723101546;0.896240625180289;[NLGN1]
GO:1902533;positive regulation of intracellular signal transduction;7.0;0.5547065974044363;0.6282726639594187;7.95454781892045;189.47637744599322;2.856402123431786;0.006341603835448636;0.4969959026857851;[, PHB2, AKT1, PROK2, CYP1B1, WLS, PRKCE, ATF3, SEH1L, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, PRKCZ, PDGFD, PDGFC, S100A12, HMOX1, ICOS, ELANE, LYN, NDFIP2, JUN, FZD5, PLK2, FZD8, EIF2AK2, NOX4, GPR18, NOX1, EZH2, JPH2, TIMP2, HAVCR2, GPR37, GPR35, RIPK2, FCRL3, SIRT1, F3, DUSP6, HCLS1, PLCB1, HBEGF, ENG, CCL13, GPNMB, NTF3, FLNA, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, COL3A1, PKN1, PF4, CSF3, NCF1, TNF, CTGF, FGF5, PYCARD, MAP2K2, IGFBP5, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, S100A9, S100A8, CSF1R, TNFRSF11A, NACC2, PSAP, DRD4, MAP2K6, TNFRSF10B, CXCL10, CXCL11, CDK1, BCL2, CSPG4, CCDC22, HPSE, MYD88, BCL2L1, PLEKHF1, LRRK2, PIK3CD, TREM2, FASLG, PTPN22, ARRB1, ARRB2, CHUK, LCK, XCL2, XCL1, BIRC2, BIRC3, NLGN1, HDAC2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, P2RX5, PTPN6, FCGR2B, IL1RN, ICAM1, LGALS1, DHX58, TNFSF11, TRIM25, EPHB2, EPHB1, ACTN4, MIF, EREG, BTC, IL23A, RRAGD, EPHA3, EPHA2, TGFA, PIK3R5, CD19, CD14, SLAMF1, CCR1, TNFSF14, LIF, PTK2, MARCO, CD28, CD27, CALM3, CD24, NRP1, ECM1, CD40, IFNA2, SECTM1, PRL, CD3E, AKAP12, CCR7, CD36, MAP4K1, EDN1, SYK, GAB1, IL18, PARP9, ZDHHC17, VAV1, MDFIC, BANK1, IL1B, KIT, TLR7, TLR6, TLR4, TLR2, CXCR4, GNAI2, PAK1, CD74, OSM, NLRP12, KITLG, CD40LG, NEDD4, IL18R1, F2RL3, CD86, GOLT1B, CD80, IL6R, PDGFRB, PDGFRA, CARD11, C5AR1, ADRB2, DDX60, RASGRP1, RASGRP4, ECT2, TGFB2, TGFB1, CAV2, CAV1, SELP, GH1, IL6, BMP2, LIN28A, IL7R, CXCL9, GHR, NUP62, DCN, FGR, GREM1, ZAP70, IFNG, CHI3L1, PDE5A, LTF, THBS1, TRAT1, EGF, MAPK14, CD4, LTBR, TEK]
GO:0042359;vitamin D metabolic process;5.0;0.7763722522362496;0.6784271379790451;9.193206181234276;64.81312882788913;7.138016298065211;0.0021692370938404806;0.6552794972956795;[CUBN, VDR, LRP2, CYP3A4]
GO:0099054;presynapse assembly;4.0;1.0;0.75;9.628524252492122;34.5996765512564;7.474488534686424;0.0011580200364832854;0.6322456912631272;[NLGN4Y, FZD1, NLGN1]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[ABCB4, SLC22A2, SLC1A3, SLC7A11, LRP2, SLC1A6, AQP1, SLC17A6, SLC17A3, SLC19A2, ABCC3, ABCA8, RHAG, ABCG2]
GO:0072162;metanephric mesenchymal cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;73.29838936289404;8.16763571524637;0.0024532311277084;0.7686126355688037;[PAX2]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, FRZB, HOXA7, A2M, EOMES, MEF2C, TGFB2, ACE, LIF, HNF1B, RUNX2, PAX2, LIN28A, KIT, HOXB4]
GO:0072289;metanephric nephron tubule formation;7.0;1.0;0.8509193652572005;9.628524252492122;32.06230107899686;8.390779266560578;0.0010730963629164269;0.7800242071602487;[PAX2]
GO:0140058;neuron projection arborization;8.0;0.8436909121759173;0.7968454560879586;9.420884887713877;64.60914726719044;7.57984905034425;0.0021624100145753813;0.7626338329336335;[NRP1, NLGN1, LRRK2, LRP2]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0045918;negative regulation of cytolysis;5.0;0.8259837884571596;0.7032329060895001;9.377209824211215;41.247147119458;8.390779266560578;0.0013805048940658876;0.7193458537639684;[PAX2, PF4]
GO:1900244;positive regulation of synaptic vesicle endocytosis;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;265.8961164942356;7.9853141584524145;0.008899303728093307;0.7833693374183408;[NLGN1, LRRK2]
GO:0008652;cellular amino acid biosynthetic process;7.0;0.5434879515166714;0.6226633410155362;8.113397019529263;297.30444561691337;5.358233019883872;0.009950512238168282;0.6249396510773795;[BHMT2, CAD, UPB1, MTHFD1, DPYD, BCAT1, ASPA, SLC1A3, AGXT2, BHMT, ALDH18A1, SERINC5]
GO:0015739;sialic acid transport;8.0;1.0;0.875;9.628524252492122;68.10037139483991;8.16763571524637;0.0022792581442300838;0.7926932703116032;[SLC17A1, SLC17A3]
GO:0010841;positive regulation of circadian sleep/wake cycle, wakefulness;6.0;1.0;0.8231203125901445;9.628524252492122;109.56266212983566;8.390779266560578;0.0036669637014913365;0.7522251544931926;[NLGN1]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC24A2, SLC24A1, SLC24A4, SLC5A10, SLC8A1, SLC17A1, SCN3A, SLC17A3, SCN1A, SLC13A1, SLC12A2, SLC6A16, SLC6A15, SLC12A1, SLC6A13, SLC6A12, ATP1B2, ATP1B1, SLC6A6, FXYD2, CAPS2]
GO:2000463;positive regulation of excitatory postsynaptic potential;8.0;0.9326813400603323;0.8413406700301662;9.589303539338841;397.97278468673557;6.518977089658987;0.013319790951212034;0.7083807915285978;[NLGN1, ADRB2, SHANK3, PRKCZ]
GO:0015855;pyrimidine nucleobase transport;6.0;0.811012628672052;0.7286266269261705;9.271849308553389;30.144488250768884;8.390779266560578;0.001008908893475126;0.7522251544931926;[AQP9, SLC28A1]
